Phathom Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:PHAT) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 63.57 M63.46 M84.93 M62.73 M14.12 M5 M 166.78 M Cash from investing activities 44 K5 00018 K97 K27 K87 K 229 K Cash from financing activities 122.06 M26.05 M080 K111 K97 K 288 K Free cash flow 63.53 M63.45 M84.91 M62.63 M14.09 M4.91 M 166.55 M

뉴스

Guggenheim relève l’objectif de cours de Phathom à 25$ après des résultats supérieurs

Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call Transcript

Stifel réitère sa recommandation d’achat sur Phathom, maintient l’objectif de 28$

Stifel reiterates Buy on Phathom stock, keeps $28 price target

Phathom T4 2025 : croissance du chiffre d’affaires de 217%

Phathom Q4 2025 slides: 217% revenue growth, profitability in sight

Le BPA de Phathom Pharma a dépassé les attentes de 0,34$, le CA a surpassé les prévisions

Phathom Pharma earnings beat by $0.34, revenue topped estimates

Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates

Phathom Pharmaceuticals stock maintains Buy rating at Stifel on strong revenue outlook

Cantor Fitzgerald reiterates Overweight rating on Phathom stock at $29

Phathom: Why I’m Not Buying The Dip (Yet) (NASDAQ:PHAT)